2018 Q2 Sentiment for Morgan Stanley Emerging Markets Debt Fund Inc (NYSE:MSD) at 1.46

Morgan Stanley Emerging Markets Debt Fund Inc’s Sentiment

“Big money sentiment for Morgan Stanley Emerging Markets Debt Fund Inc (NYSE:MSD) in 2018 Q2 decreased to 1.46, according to SEC filings. So its down -0.84, from 2018Q1’s 2.3. 19 investment managers increased or started new equity positions, while 13 sold and decreased their equity positions in Morgan Stanley Emerging Markets Debt Fund Inc so the sentiment has dropped. Funds own 6.28 million shares, up from 6.00 million shares in 2018Q1. Funds holding Morgan Stanley Emerging Markets Debt Fund Inc in top 10 was flat from 0 to 0 for the same number . 4 Investors Sold All; 9 Reduced Holdings; 9 increased holdings while 10 investment managers bought holdings.

Biggest Morgan Stanley Emerging Markets Debt Fund Inc Investors

Rivernorth Capital Management Llc owns 1.18 million shares in Morgan Stanley Emerging Markets Debt Fund Inc as of 2018 Q2. Morgan Stanley Emerging Markets Debt Fund Inc’s shareholder Saba Capital Management L.P. owns 1.01 million shares as of 2018 Q2. Also, Sit Investment Associates Inc reported 1.34 million shares in Morgan Stanley Emerging Markets Debt Fund Inc equivalent to 0.3% of its fund portfolio. Shaker Financial Services Llc revealed 13,220 shares position in Morgan Stanley Emerging Markets Debt Fund Inc. The New Jersey-based fund Landscape Capital Management L.L.C. holds 50,771 shares or 0.04% of their fund portfolio.

MSD touched $8.49 during the last trading session after $0.06 change.Morgan Stanley Emerging Markets has 145,444 shares volume, 49.89% up from normal. MSD is downtrending and has moved 15.05% since December 8, 2017. The stock underperformed the S&P500 by 30.67%.

The Ontario – Canada-based Royal Savings Bank Of Canada has invested 0% in Morgan Stanley Emerging Markets (NYSE:MSD). Washington Tru holds 4,334 shs. Landscape Cap Limited Liability Com, a New Jersey-based fund reported 50,771 shs. Saba Cap Lp reported 1.01M shs stake. Shaker Financial Ser Ltd Liability stated it has 0.06% of its capital in Morgan Stanley Emerging Markets (NYSE:MSD). Northwestern Mutual Wealth Com stated it has 0% of its capital in Morgan Stanley Emerging Markets (NYSE:MSD). Ftb Advsrs reported 0% of its capital in Morgan Stanley Emerging Markets (NYSE:MSD). Blackrock stated it has 0% in Morgan Stanley Emerging Markets (NYSE:MSD). Reilly Financial Ltd Liability Corp has invested 0% of its capital in Morgan Stanley Emerging Markets (NYSE:MSD). New York-based Morgan Stanley has invested 0% in Morgan Stanley Emerging Markets (NYSE:MSD). Sei accumulated 5,155 shs. Walleye Trading Limited Com invested in 0% or 68,748 shs. Stifel owns 0% invested in Morgan Stanley Emerging Markets (NYSE:MSD) for 25,738 shs. Ameriprise Financial Inc holds 0% of its capital in Morgan Stanley Emerging Markets (NYSE:MSD) for 13,564 shs. 10,000 were accumulated by Da Davidson Company.

For more Morgan Stanley Emerging Markets (NYSE:MSD) news announced briefly go to: Streetinsider.com, Businesswire.com, Prnewswire.com, Streetinsider.com or Businesswire.com. The titles are as follows: “Merck (MRK) Announces FDA Approval of KEYTRUDA for Treatment of Patients with HCC Who Have Been Previously Treated with Sorafenib – StreetInsider.com” announced on November 09, 2018, “New Data from Investigational Study of LENVIMA┬« (lenvatinib) and KEYTRUDA┬« (pembrolizumab) Combination in Three Different Tumor Types Presented at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting – Business Wire” on November 09, 2018, “The Global Cancer Therapy Market is set to Grow on the Wide use of Chemotherapy – PRNewswire” with a publish date: November 28, 2018, “Merck (MRK) Begins Rolling Submission of Licensure Application for V920 to FDA – StreetInsider.com” and the last “Merck to Present at the Citi 2018 Global Healthcare Conference – Business Wire” with publication date: December 03, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.